TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06228859

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: overdentures with different attachments
Description: different types of overdenture attachments in relation to retention, bite force, and periimplant tissue health.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: overdentures with different attachments
Description: different types of overdenture attachments in relation to retention, bite force, and periimplant tissue health.
Study: NCT05295355

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tiotropium Bromide Combined With Odaterol
Description: 2 puffs once daily at the same time of the day for 52 week

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tiotropium Bromide Combined With Odaterol
Description: 2 puffs once daily at the same time of the day for 52 week
Study: NCT05165186

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video Intervention Arm
Description: For participants randomized to the video intervention arm, participants will be shown two videos about Advanced Care Planning, and then they will be asked questions regarding the usefulness of the video and their comfort with the video.
Study: NCT04929314

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Systematic Interactive Communication Model to Strengthen Self-Care Regardless of Health Literacy Level
Description: The central element of the intervention is the interactive communication model. A website that contains easy-to-understand knowledge and material about various chronic diseases such as chronic obstructive pulmonary disease, diabetes, heart failure, as well as knowledge and material about wound care, compression treatment and prevention of infections has been developed. Information within each topic is given based on the interactive communication model. The idea is that community nurses should not themselves assess what characterizes an easy-to-understand level or the amount of information for each individual citizen, which seeks to ensure a systematic and uniformity in the work with self-care and more self-sufficient citizens. At the same time, the model makes it possible to take into account the individual citizen's knowledge and competencies (level of HL). Further, the nurses receive specialised education regarding HL to complement their use of the interactive communication model.
Study: NCT06381388

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cTBS
Description: A single cTBS session delivered to the contralesional primary motor cortex.
Study: NCT06119802

Intervention type: DIAGNOSTIC_TEST
Intervention: atrial fibrillation
Description: ECG of atrial fibrillation last more than 30 seconds.
Study: NCT06412809

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined Land- and Water-Based Exercise
Description: Strengthening exercises targeting the core and lower extremities (quadriceps, hamstring, and gastrocnemius) were implemented both on land and in water. The exercises are done for approximately one hour/day, three days/week for two consecutive weeks. The following are the included exercises:~Land-based exercise:~1. Plank exercise~2. Russian twist~3. Push-up~4. Goblet squat~5. Kettle bell swing~Water-based exercise:~1. Flutter kicks~2. Isometric core crunches~3. Jump lunges~4. Kicks~5. Resisted knee flexion
Study: NCT06186674

Intervention type: DIAGNOSTIC_TEST
Intervention: sorensen test for back endurance
Description: • Biering-Sorensen test will be utilized to gauge the trunk extensor muscles' isometric endurance. The patient will be lying on a treatment couch, prone. The top half of the body will be permitted to rest on a chair prior to the test starting. The patient will be told to elevate their upper trunks off of the chair at the start of the test. the examiner determined how long the individual could hold this position.
Study: NCT06412809

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Land-Based Exercise
Description: Strengthening exercises targeting the core and lower extremities (quadriceps, hamstring, and gastrocnemius) were implemented on land. The exercises are done for approximately one hour/day, three days/week for two consecutive weeks. The following are the included exercises:~1. Plank exercise~2. Russian twist~3. Dead bug~4. Push-up~5. Goblet squat~6. Nordic hamstring curl~7. Lunges~8. Kettle bell swing~9. Calf raises~10. Bird dog

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Water-Based Exercise
Description: Strengthening exercises targeting the core and lower extremities (quadriceps, hamstring, and gastrocnemius) were implemented in the water. The exercises are done for approximately one hour/day, three days/week for two consecutive weeks. The following are the included exercises:~1. Core pulls~2. Flutter kicks~3. Water cycling~4. Isometric core crunches~5. Seated push-up~6. Jump squats~7. Jump lunges~8. Kicks~9. Ankle jumps~10. Resisted knee flexion
Study: NCT03979040

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group Transdiagnostic Behavior Therapy
Description: TBT was developed to address transdiagnostic avoidance via the use of four different types of exposure techniques (situational/in-vivo, physical/interoceptive, thought/imaginal, and \[positive\] emotional/behavioral activation). From the transdiagnostic avoidance perspective, the four exposure practices are matched to the type(s) of avoidance experienced by patients based upon their cluster of symptoms/disorders. Per protocol, the first six sessions of TBT are designed to educate on, prepare for, and practice the four different types of exposure techniques. The next five sessions are focused on practicing and refining exposure practices as participants work through their lists of avoided situations/sensation/thoughts. The final session reviews treatment progress and relapse prevention strategies.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Group Disorder-Specific Therapy (G-DSTs)
Description: To provide an evidence-based comparison for the G-TBT condition, G-DSTs will be used that are matched to the participant's principal diagnosis. G-DSTs will include groups for the most common principal diagnoses that have VA-approved protocols and training programs, including PTSD (Cognitive Processing Therapy for PTSD) and Depression (CBT-Depression). Each of these G-DSTs have published manuals for administration and have received extensive support in the literature.
Study: NCT05642299

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MBCI-SR
Description: Participants will be asked to wear and EEG+NIRS cap and a soft robotic glove on their stroke-impaired hand. The participant will be instructed to ask to imagine to picture moving the stroke-imparied hand in the mind. The brain signal (EEG and NIRS data) will be recorded as a reference. When the participant pictures this move again, upon detection of such imagined move by MBCI-SR system, the glove will be activated and assists the participants to perform a specific upper limb task based on individual ability. There are six different activities of daily living (ADL)-oriented tasks enacted through a virtual arm and virtual objects, which formed the visual feedback for the participants. These tasks include scanning goods, moving an object upward to a cabinet, using two hands to move a towel, pouring of water into a cup, eating action and fine motor movement of picking up a small block using two fingers. Training intensity is 1.5 hours for 3 times a week for 6 weeks, a total of 18 sessions.
Study: NCT06186674

Intervention type: DIAGNOSTIC_TEST
Intervention: sorensen test for back endurance
Description: • Biering-Sorensen test will be utilized to gauge the trunk extensor muscles' isometric endurance. The patient will be lying on a treatment couch, prone. The top half of the body will be permitted to rest on a chair prior to the test starting. The patient will be told to elevate their upper trunks off of the chair at the start of the test. the examiner determined how long the individual could hold this position.

Intervention type: DIAGNOSTIC_TEST
Intervention: 6 minute walk test
Description: It gauges how far a person can go while walking for a total of six minutes on a level, hard surface. Cones will be used to mark turns at the start and end of the 30-meter border and every three meters throughout the corridor or walkway that was utilized for the test. The patient's objective is to cover the most distance in six minutes at a reasonable pace.~It gauges how far a person can go while walking for a total of six minutes on a level, hard surface. Cones will be used to mark turns at the start and end of the 30-meter border and every three meters throughout the corridor or walkway that was utilized for the test. The patient's objective is to cover the most distance in six minutes at a reasonable pace.

Intervention type: DIAGNOSTIC_TEST
Intervention: 6 minute walk test
Description: It gauges how far a person can go while walking for a total of six minutes on a level, hard surface. Cones will be used to mark turns at the start and end of the 30-meter border and every three meters throughout the corridor or walkway that was utilized for the test. The patient's objective is to cover the most distance in six minutes at a reasonable pace.~It gauges how far a person can go while walking for a total of six minutes on a level, hard surface. Cones will be used to mark turns at the start and end of the 30-meter border and every three meters throughout the corridor or walkway that was utilized for the test. The patient's objective is to cover the most distance in six minutes at a reasonable pace.

Intervention type: DIAGNOSTIC_TEST
Intervention: c7-s1 SVA
Description: Subjects will obtain standardized lateral views radiographs in a neutral standing position for the whole spine. The C7- S1 SVA will be measured as the distance from the plumb line dropped from the center of the C7 vertebral body to the most posterior edge of the upper sacral endplate surface.

Intervention type: DIAGNOSTIC_TEST
Intervention: c7-s1 SVA
Description: Subjects will obtain standardized lateral views radiographs in a neutral standing position for the whole spine. The C7- S1 SVA will be measured as the distance from the plumb line dropped from the center of the C7 vertebral body to the most posterior edge of the upper sacral endplate surface.
Study: NCT05747170

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Olfactory sstimulation
Description: The odors being tested (natural odor, neutral odor, chemical odor) are part of the 40 fragrances made by International Flavors and Fragrances (IFF) and each is contained in an approximately 15-mL glass bottle. The selected odors will be administered using a small paper strip (15 cm length and 0.7 cm width) that will be soaked in the selected odor and placed under the subject's nose at a minimum distance to prevent direct contact of the strip with the skin; the strip will be moved alternately from one nostril to the other.~Stimulation will have, for each odor the duration of 5 minutes. It will always be carried out within the same time slot (between 8:00 am and 4:00 pm) for 5 consecutive days for 2 weeks. Before and after the administration of each odor, a neutral odor (water) will be administered as a control in the same manner as described above.~The sequence of odor administration will be randomized according to a computer-generated sequence.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Olfactory sstimulation
Description: The odors being tested (natural odor, neutral odor, chemical odor) are part of the 40 fragrances made by International Flavors and Fragrances (IFF) and each is contained in an approximately 15-mL glass bottle. The selected odors will be administered using a small paper strip (15 cm length and 0.7 cm width) that will be soaked in the selected odor and placed under the subject's nose at a minimum distance to prevent direct contact of the strip with the skin; the strip will be moved alternately from one nostril to the other.~Stimulation will have, for each odor the duration of 5 minutes. It will always be carried out within the same time slot (between 8:00 am and 4:00 pm) for 5 consecutive days for 2 weeks. Before and after the administration of each odor, a neutral odor (water) will be administered as a control in the same manner as described above.~The sequence of odor administration will be randomized according to a computer-generated sequence.
Study: NCT05032196

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WVE-003
Description: WVE-003 is a stereopure antisense oligonucleotide (ASO)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WVE-003
Description: WVE-003 is a stereopure antisense oligonucleotide (ASO)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WVE-003
Description: WVE-003 is a stereopure antisense oligonucleotide (ASO)
Study: NCT05115812

Intervention type: PROCEDURE
Intervention: Pre-Operative Information
Description: Demographics (e.g., age, gender), patient characteristics (e.g., BMI, American Society of Anesthesiologists class), and pre-operative medical history (e.g., tobacco use; comorbidities: hypertension, cardiopulmonary disease, diabetes; indication for RAT; lesions; previous renal revascularization; serum creatinine level).

Intervention type: PROCEDURE
Intervention: Intra-Operative Data
Description: Operative time, total OR time, concomitant procedures, transfusions, conversions, intraoperative adverse events, autotransplantation technique

Intervention type: OTHER
Intervention: Post-Operative Data (up to discharge)
Description: Postoperative adverse events, discharge status, hospital length of stay, information on enhanced recovery program

Intervention type: OTHER
Intervention: Short-Term Follow-Up Data
Description: Adverse events, re- admissions, re-operations related to the index procedure
Study: NCT05363787

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: therapeutic touch
Description: Therapeutic Touch (TT) is an evidence-based holistic treatment method in which universal energy is used intentionally and with compassion for a specific purpose, in order to contribute to one's balance and recovery.In a world dominated by technology, one can lose touch with our inner self. We lose our intuitive abilities for beautiful everyday sensations of nature, the surrounding environment, and various visual and auditory elements. The Therapeutic Touch is an ancient Ayurvedic self-massage technique that connects your body to your soul.It is also used in therapeutic communication. Therapeutic communication is the process of influencing and being influenced by one another. It consists of individual-centered, purposeful, planned, effective and satisfying actions.
Study: NCT05034029

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin hydrochloride sustained release tablets
Description: Oral

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT04680273

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]-GDC-9545
Description: Participants will receive a single oral dose of \[14C\]-GDC-9545 capsule, 30 milligrams (mg) (not more than \[NMT\] 4.6 megabecquerel \[MBq\]; 124 microcurie \[μCi\]) with approximately 240 millilitres (mL) water in the fasted state.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GDC-9545 Solution for Infusion
Description: Treatment B: 30 mg GDC-9545 as a solution for infusion, 3 mg/mL administered intravenously (IV) in 10 mL as an infusion over 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GDC-9545 Solution for Infusion
Description: Treatment B: 30 mg GDC-9545 as a solution for infusion, 3 mg/mL administered intravenously (IV) in 10 mL as an infusion over 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GDC-9545/F12 Capsule
Description: Treatment C: GDC-9545/F12 capsule, 30 mg, administered orally with approximately 240 mL water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GDC-9545/F12 Capsule
Description: Treatment C: GDC-9545/F12 capsule, 30 mg, administered orally with approximately 240 mL water.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GDC-9545/F18 Capsule
Description: Treatment D: GDC-9545/F18 capsule, 30 mg, administered orally with approximately 240 mL water.
Study: NCT06260306

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hip activation home exercise program
Description: The hip activation HEP group will receive a combination of hip musculature activation exercises used by previous researchers that show an increase in hip muscle recruitment. Each participant will perform their respective intervention program at home twice weekly for eight weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hip activation plus core stabilization home exercise program
Description: The hip activation plus core stabilization HEP group will receive the same hip exercises, plus core stabilization exercises used by previous researchers. Each participant will perform their respective intervention program at home twice weekly for eight weeks.
Study: NCT06040801

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Frailty intervention measures
Description: Providing management and recommendations based on the specific impairment domain.~Assessment domain:~* Functional status~* Nutrition~* Comorbidity~* Mobility/Falls~* Mood~* Cognition~* Polypharmacy~* Social support.
Study: NCT05368168

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Posterior tibial nerve stimulation (PTNS)
Description: Posterior tibial nerve neurostimulation in postoperative patients treated for rectal neoplasms for 6 weeks at a rate of 2 sessions per week (12 sessions).~The sessions will be carried out by the nursing staff of the anorectal functional testing cabinet. The sessions will begin 3 weeks after hospital discharge for patients without lateral ileostomy and after ileostomy closure for patients with lateral ileostomy.
Study: NCT05094219

Intervention type: OTHER
Intervention: No intervention will be offered
Description: No intervention will be offered
Study: NCT06134843

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: DERMASEAL
Description: plasma film containing metallic silver microparticles and fibrin
Study: NCT05374330

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Description: Acupuncture needles are inserted into the body at standardized acupuncture points. An electrical current is then applied to 4 needles through 2 channels of electrical current. The sham group receives the same protocol with sham needles and sham electrical current.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Electroacupuncture
Description: Acupuncture needles are inserted into the body at standardized acupuncture points. An electrical current is then applied to 4 needles through 2 channels of electrical current. The sham group receives the same protocol with sham needles and sham electrical current.
Study: NCT04680273

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GDC-9545/F18 Capsule
Description: Treatment D: GDC-9545/F18 capsule, 30 mg, administered orally with approximately 240 mL water.
Study: NCT05628077

Intervention type: OTHER
Intervention: No intervention
Description: No intervention

Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study: NCT06510192

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yuva Sath
Description: The Yuva Sath Intervention comprises 6 one-on-one sessions with peer counselors who will use an intervention manual. The intervention also includes weekly phone text check-ins by peer counselors
Study: NCT00012870

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Behavioral Management
Study: NCT04851899

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Phaeosol low dose
Description: 1 Phaeosol softgel of 440mg/day and 1 placebo softgel of 500mg/day (look like softgel of Phaeosol product) + 1 capsule of 440mg/day of natural stimulant Subjects were instructed to take the study supplement or placebo once daily for 1 months (±2 days). The first and the last doses will be administered at the clinical site during Visit 2 (Experiment 1) and Visit 3 (Experiment 2, respectively).

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Phaeosol high dose
Description: 2 Phaeosol softgels of 440mg/day + 1 capsule of 440mg/day of natural stimulant. Subjects were instructed to take the study supplement or placebo once daily for 1 months (±2 days). The first and the last doses will be administered at the clinical site during Visit 2 (Experiment 1) and Visit 3 (Experiment 2, respectively).

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 placebo softgels of 440mg/day (look like softgel of Phaeosol product) + 1 capsule of 500mg/day containing Microcellulose (look like capsule of natural stimulant). Subjects were instructed to take the study supplement or placebo once daily for 1 months (±2 days). The first and the last doses will be administered at the clinical site during Visit 2 (Experiment 1) and Visit 3 (Experiment 2, respectively).
Study: NCT04862273

Intervention type: DIAGNOSTIC_TEST
Intervention: Native T1 CMR
Description: Observed method

Intervention type: DIAGNOSTIC_TEST
Intervention: Web-based ATTR probability estimator (Pfizer, New York)
Description: Observed method

Intervention type: DIAGNOSTIC_TEST
Intervention: 99mTc-DPD scintigraphy
Description: Reference method

Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory screening for multiple myeloma / AL amyloidosis
Description: Reference method

Intervention type: PROCEDURE
Intervention: Cardiac biopsy
Description: If non-invasive tests for CA (99mTc-DPD scintigraphy, biochemistry) are inconclusive
Study: NCT03366467

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SADE
Description: The SADE: the sensory stimuli addressed are visual and auditory, as follows: (i) Visual sensation. All ceiling fluorescent lighting are removed. The adapted lighting consisted of slow-moving, repetitive visual color effects created by a projector, in the child's visual field. (ii) Auditory stimuli include rhythmic music, which was heard via loudspeakers.
Study: NCT05130736

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Robot rehabilitation
Description: Effectiveness of using a rehabilitation robot in post-COVID-19 rehabilitation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robot rehabilitation
Description: Effectiveness of using a rehabilitation robot in post-COVID-19 rehabilitation
Study: NCT05627999

Intervention type: PROCEDURE
Intervention: doppler endoanal ultrasound
Description: The primary aim was to assess the reduction in the blood supply by comparing the hemorrhoidal arterial systolic peak (overall and sectorial) before and after Emborrhoid.
Study: NCT06326138

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Edoxaban Pharmacokinetics and Pharmacodynamics
Description: Participants will be received single oral doses of edoxaban 60 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Edoxaban Pharmacokinetics and Pharmacodynamics
Description: Participants will be received single oral doses of edoxaban 60 mg.